In This Section
SNMMI Dinner Symposium: How PSMA Imaging and Therapy are Changing Care for Prostate Cancer Patients - Atlanta, GA
Free SNMMI Dinner Symposium: How PSMA Imaging and Therapy are Changing Care for Prostate Cancer Patients
Date: April 18, 2023
Time: 5:30 - 8:00 pm ET
Location: The Georgian Terrace Hotel, 659 Peachtree St. NE, Atlanta, GA 30305
Fee: Complimentary
SNMMI has applied for 1.5 hours of CE Credit for this in-person event.
Please note that seating is limited and registration will be available on a first-come, first-served basis.
SCHEDULE
5:30 pm
Registration/Networking Reception
6:00 pm
Dinner is Served
6:30-8:00 pm
Educational Program
Several new radiopharmaceuticals are now being used in both large academic and small practice settings to stage and identify local and metastatic prostate cancer, including the recently approved Ga-68 PSMA-11 and 18F-DCFPyL. In addition, the FDA in March 2022 approved Lu 177 vipivotide tetraxetan to treat PSMA-positive metastatic castration-resistant prostate cancer. Given these new advancements in diagnosis and treatment, the panel will present a comprehensive, interactive session addressing the changing landscape of prostate cancer patient management.
6:30
Welcome and Introductions
Ila Sethi, MD, Clinical Site Director, Nuclear Medicine, Emory University Hospital
6:30 - 6:55 pm
Nuclear Medicine Perspective
David M Schuster, MD, FACR, Professor of Radiology and Imaging Sciences and Urology, Emory University Hospital
6:55 - 7:20 pm
Oncologist's Perspective
Mehmet Asim Bilen, Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
7:20 - 7:45 pm
Radiation Oncologist's Perspective
Ashesh B. Jani, MD, MSEE, FASTRO, James C. Kennedy Professor, Department of Radiation Oncology, Winship Cancer Institute of Emory University
7:45 - 8:00 pm
Q&A and Panel Discussion
Please note: SNMMI is committed to ensuring that appropriate and necessary health and safety protocols will be in place for this event. We will follow all Centers for Disease Control and Prevention (CDC) safety protocols and recommendations and will comply with all federal, state, and local regulations in force at the time of the event.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SNMMI has applied for 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must complete the online assessment and evaluation available after the program.
This event is supported through a medical education grant from Lantheus Medical Imaging.